Home / Mesothelioma.net / Ultimovacs Mesothelioma Vaccine Receives FDA Orphan Drug Designation

Ultimovacs Mesothelioma Vaccine Receives FDA Orphan Drug Designation

A Norway-based pharmaceutical company’s cancer-fighting vaccine has been granted orphan drug designation for a study of its use in patients...

from Mesothelioma.net https://ift.tt/ynfeqB0
via IFTTT
Ultimovacs Mesothelioma Vaccine Receives FDA Orphan Drug Designation Ultimovacs Mesothelioma Vaccine Receives FDA Orphan Drug Designation Reviewed by Unknown on October 10, 2023 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.